Skip to main content
. Author manuscript; available in PMC: 2020 Aug 12.
Published in final edited form as: Oncogene. 2020 Feb 12;39(15):3218–3225. doi: 10.1038/s41388-020-1204-9

Table 2.

Variants detected in iMCD-TAFRO patients.

Gene Protein change Allele
Freq.
Chr. Start Pos. End pos. Ref Var SIFT
prediction
Polyphen-2
prediction
Patient 1 MAP2K2 (MEK2) P128L 0.10 19 4110574 4110574 G A Damaging Probably damaging
AR A646D 0.99 X 66931295 66931295 C A Tolerated Benign
TCF3 N347T 0.49 19 1621020 1621020 T G Tolerated Probably damaging
ARID2 T1193A 0.46 12 46245483 46245483 A G Tolerated Benign
Patient 2 KMT2B (MLL4) E373del 0.40 19 36211355 36211357 AAG A - -
MPEG1 L221I 0.50 11 58979678 58979678 G T Tolerated Benign
RUNX1 G60C 0.48 21 36259232 36259232 C A Damaging Probably damaging
Patient 3 EGFR H145R 0.46 7 55214308 55214308 A G Tolerated Benign
EPHA3 S662T 0.52 3 89462392 89462392 T G Tolerated Benign
RARA G248D 0.53 17 38508695 38508695 G A Damaging Probably damaging
SOX9 T316A 0.44 17 70119944 70119944 A A Tolerated Benign
SESN1 H47R 0.48 6 109415137 109415137 T C Tolerated Benign
SETD2 G1649E 0.46 3 47143017 47143017 C T Damaging Probably damaging
ANKRD11 A2284V 0.47 16 89346099 89346099 G A (not scored) Benign
TET3 V1137I 0.49 2 74327729 74327729 G A Tolerated Benign
ZFHX3 Q3203_Q3204del 0.28 16 72822564 72822569 TGCTGC - - -